| Date Filed | Type | Description |
| 10/06/2023 |
4
| Butchko Julia G. (Chief Development Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 296 shares
@ $35.54, valued at
$10.5k
Sold 1,439 shares
@ $36.39, valued at
$52.4k
|
|
| 08/25/2023 |
4
| Butchko Julia G. (Chief Development Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 12,332 shares
@ $20.3, valued at
$250.3k
Sold 1 shares
@ $20.89, valued at
$20.9 |
|
| 07/13/2023 |
4
| Butchko Julia G. (Chief Development Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 1,470 shares
@ $19.73, valued at
$29k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 19 shares
@ $15.16, valued at
$288
Sold 60,471 shares
@ $16.79, valued at
$1M
|
|
| 10/17/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 928 shares
@ $9.18, valued at
$8.5k
|
|
| 09/29/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 535 shares
@ $4.67, valued at
$2.5k
|
|
| 09/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 541 shares
@ $4.72, valued at
$2.6k
|
|
| 04/14/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 6,381 shares
@ $5.9, valued at
$37.6k
|
|
| 01/11/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 55,318 shares
@ $7.25, valued at
$401.1k
|
|
| 09/14/2021 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 319,700 options to buy
@ $8.62, valued at
$2.8M
Disposed/sold 319,700 options to buy
@ $19.01, valued at
$6.1M
Granted 191,100 options to buy
@ $8.62, valued at
$1.6M
Disposed/sold 191,100 options to buy
@ $17, valued at
$3.2M
|
|
| 03/23/2021 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 54,500 shares
@ $0
Granted 191,100 options to buy
@ $17, valued at
$3.2M
|
|
| 09/15/2020 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Bought 5,000 shares
@ $38.17, valued at
$190.9k
|
|
| 05/18/2020 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 319,700 options to buy
@ $19.01, valued at
$6.1M
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |